The 'ideal' management of retinopathy of prematurity

G E Quinn1

  • 1The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. quinn@email.chop.edu

Eye (London, England)
|November 24, 2005
PubMed

Insights

Early detection and treatment of retinopathy of prematurity in premature infants can prevent blindness. Guidelines for detection and treatment must be adapted for varying demographics, especially in developing countries, as outcomes are not always successful.

Area of Science:

  • Ophthalmology
  • Neonatology
  • Public Health

Background:

  • Retinopathy of prematurity (ROP) is a significant, preventable cause of blindness in premature infants.
  • Increasing survival rates of premature infants heighten the importance of ROP detection and management.
  • Existing ROP detection guidelines (e.g., US, UK) may not be suitable for Medium Human Development Countries.

Purpose of the Study:

  • To address the identification of infants at risk for retinopathy of prematurity.
  • To outline the detection and treatment of serious ROP.
  • To provide guidance on managing treatment failures in ROP.

Main Methods:

  • Review of current practices and guidelines for ROP screening.
  • Analysis of risk factors and demographic variations in premature infants.
  • Discussion of evolving treatment criteria and therapeutic approaches.

Main Results:

  • ROP predominantly affects small premature infants, with demographic variations globally.
  • Carefully timed examinations are crucial for detecting serious ROP.
  • Treatment criteria for ROP are subject to change with new therapeutic developments.

Conclusions:

  • Timely ROP detection and treatment are essential to minimize blindness risk.
  • While effective, ROP interventions are not universally successful.
  • Adaptation of ROP management strategies is necessary for diverse healthcare settings.
Abstract